Notice of Intent to Award Sole Source

The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, issued a Notice of Intent to Award Sole Source on January 8, 2026, for servicing and maintenance of AB Sciex laboratory equipment. This special notice indicates the government's intention to award a firm fixed-price purchase order directly to AB Sciex under the authority of FAR 13.106-1(b) as a sole source procurement. The CDC determined that AB Sciex laboratory equipment is highly technical and only one source can adequately perform the required work. While this notice represents an intent to award without competition, the CDC has opened a 10-day window for all responsible sources to submit capability statements, proposals, or quotations for consideration. The government retains sole discretion in determining whether to conduct a competitive procurement based on responses received.

The contract's primary objective is to maintain the functionality and reliability of AB Sciex mass spectrometers, liquid chromatographs, and associated laboratory equipment critical to the CDC's public health missions, including chemical terrorism analysis and emergency response. The contract period runs from May 1, 2026, through April 30, 2031, with a base period and four optional renewal periods, covering hundreds of instruments across multiple CDC organizational branches. Interested contractors must submit their quotations or capability statements by January 21, 2026, to the CDC contract specialist via email, and all responsible sources are eligible to participate regardless of prior relationship status with the government. Key requirements include providing Sciex-certified technicians, ensuring at least 95% operational uptime, responding to service calls within 24 hours, and maintaining detailed service records with monthly reports and quarterly conference calls. The CDC will evaluate proposals primarily on technical approach and staffing qualifications, with technical factors weighted more heavily than pricing considerations.